Pituitary tumor-transforming gene 1 protein (PTTG)-interacting protein, also known as PTTG-binding factor (PBF), is encoded by a proto-oncogene PTTG1IP. PBF has been identified through its interaction with PTTG. Similar to PTTG, PBF has been implicated in the etiology of several tumors, including pituitary, thyroid, and breast cancer. PBF can induce the translocation of PTTG into the nucleus, and then lead to tumorigenesis. Studies have shown that PBF plays a vital and complex role in increasing tumor development. However, the transcriptional regulation of PTTG1IP gene remains undefined. In this study, we have cloned a 467-bp fragment of the 5′ flanking region of the human PTTG1IP gene and identified the region (−212 to +7 bp) necessary for PTTG1IP gene promoter activity by luciferase assay. Electrophoretic mobility shift assay revealed PTTG1IP gene promoter containing Sp4 response elements. Overexpression of Sp4 increased PTTG1IP gene transcription and expression in HeLa cells. Our study demonstrates that Sp4 regulates PTTG1IP gene transcription and expression.
Get full access to this article
View all access options for this article.
References
1.
AbdelrahimM, SmithR 3rd, BurghardtR, et al.Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res, 2004; 64(18):6740–6749; doi: 10.1158/0008-5472.Can-04-0713
BlackAR, BlackJD, Azizkhan-CliffordJ. Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol, 2001; 188(2):143–160; doi: 10.1002/jcp.1111
4.
BorkP, DoerksT, SpringerTA, et al.Domains in plexins: Links to integrins and transcription factors. Trends Biochem Sci, 1999; 24(7):261–263; doi: 10.1016/s0968-0004(99)01416-4
5.
ChienW, PeiL. A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. J Biol Chem, 2000; 275(25):19422–19427; doi: 10.1074/jbc.M910105199
6.
FinkenzellerG, SparacioA, TechnauA, et al.Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene, 1997; 15(6):669–676; doi: 10.1038/sj.onc.1201219
7.
HsuehC, LinJD, ChangYS, et al.Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma. Clin Endocrinol, 2013; 78(2):303–309; doi: 10.1111/cen.12007
8.
KaminskySM, LevyO, SalvadorC, et al.Na(+)-I- symport activity is present in membrane vesicles from thyrotropin-deprived non-I(-)-transporting cultured thyroid cells. Proc Natl Acad Sci U S A, 1994; 91(9):3789–3793; doi: 10.1073/pnas.91.9.3789
9.
KirkbrideKC, SungBH, SinhaS, et al.Cortactin: A multifunctional regulator of cellular invasiveness. Cell Adhes Migr, 2011; 5(2):187–198; doi: 10.4161/cam.5.2.14773
10.
MacGrathSM, KoleskeAJ. Cortactin in cell migration and cancer at a glance. J Cell Sci, 2012; 125(Pt 7):1621–1626; doi: 10.1242/jcs.093781
11.
McCabeCJ, KhairaJS, BoelaertK, et al.Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: Relationships to clinical tumour behaviour. Clin Endocrinol, 2003; 58(2):141–150; doi: 10.1046/j.1365-2265.2003.01598.x
12.
MelloniGE, OgierAG, de PretisS, et al.DOTS-Finder: A comprehensive tool for assessing driver genes in cancer genomes. Genome Med, 2014; 6(6):44; doi: 10.1186/gm563
13.
MoZ, ZuX, XieZ, et al.Antitumor effect of F-PBF(beta-TrCP)-induced targeted PTTG1 degradation in HeLa cells. J Biotechnol, 2009; 139(1):6–11; doi: 10.1016/j.jbiotec.2008.09.004
PollardTD, BorisyGG. Cellular motility driven by assembly and disassembly of actin filaments. Cell, 2003; 112(4):453–465; doi: 10.1016/s0092-8674(03)00120-x
16.
ReadML, SeedRI, ModasiaB, et al.The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer. Mol Carcinog, 2016; 55(1):15–26; doi: 10.1002/mc.22254
17.
RyutoM, OnoM, IzumiH, et al.Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem, 1996; 271(45):28220–28228; doi: 10.1074/jbc.271.45.28220
18.
SafeS, AbdelrahimM. Sp transcription factor family and its role in cancer. Eur J Cancer (Oxford, England: 1990), 2005; 41(16):2438–2448; doi: 10.1016/j.ejca.2005.08.006
19.
SafeS, ImaniradP, SreevalsanS, et al.Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target. Expert Opin Ther Targets, 2014; 18(7):759–769; doi: 10.1517/14728222.2014.914173
20.
ShiQ, LeX, AbbruzzeseJL, et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 2001;61(10):4143–4154.
21.
SmithVE, FranklynJA, McCabeCJ. Pituitary tumor-transforming gene and its binding factor in endocrine cancer. Expert Rev Mol Med, 2010; 12:e38; doi: 10.1017/s1462399410001699
22.
SmithVE, ReadML, TurnellAS, et al.A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer. J Cell Sci, 2009; 122(Pt 18):3393–3402; doi: 10.1242/jcs.045427
23.
StonerM, WormkeM, SavilleB, et al.Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene, 2004; 23(5):1052–1063; doi: 10.1038/sj.onc.1207201
24.
StratfordAL, BoelaertK, TannahillLA, et al.Pituitary tumor transforming gene binding factor: A novel transforming gene in thyroid tumorigenesis. J Clin Endocrinol Metab, 2005; 90(7):4341–4349; doi: 10.1210/jc.2005-0523
25.
UrunoT, LiuJ, ZhangP, et al.Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol, 2001; 3(3):259–266; doi: 10.1038/35060051
26.
WatkinsRJ, ImruetaicharoenchokeW, ReadML, et al.Pro-invasive effect of proto-oncogene PBF is modulated by an interaction with cortactin. J Clin Endocrinol Metab, 2016; 101(12):4551–4563; doi: 10.1210/jc.2016-1932
27.
WatkinsRJ, ReadML, SmithVE, et al.Pituitary tumor transforming gene binding factor: A new gene in breast cancer. Cancer Res, 2010; 70(9):3739–3749; doi: 10.1158/0008-5472.Can-09-3531
28.
WeaverAM, KarginovAV, KinleyAW, et al.Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol, 2001; 11(5):370–374; doi: 10.1016/s0960-9822(01)00098-7
29.
XiangC, GaoH, MengL, et al.Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer. Cancer Sci, 2012; 103(6):1121–1128; doi: 10.1111/j.1349-7006.2012.02266.x
30.
YaspoML, AaltonenJ, Horelli-KuitunenN, et al.Cloning of a novel human putative type Ia integral membrane protein mapping to 21q22.3. Genomics, 1998; 49(1):133–136; doi: 10.1006/geno.1998.5217
